May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Effect of Ocular Hypertension on the Retinal Glutamate/Glutamine Cycle Activity
Author Affiliations & Notes
  • M.C. Moreno
    Hunman Biochemistry, Sch Med–Univ Buenos Aires, Capital Federal, Argentina
  • P.H. Sande
    Hunman Biochemistry, Sch Med–Univ Buenos Aires, Capital Federal, Argentina
  • N. de Zavalía
    Hunman Biochemistry, Sch Med–Univ Buenos Aires, Capital Federal, Argentina
  • M.I. Keller Sarmiento
    Hunman Biochemistry, Sch Med–Univ Buenos Aires, Capital Federal, Argentina
  • H.J. Aldana Marcos
    Embriology and Histology, School of Medicine, University of Morón, Morón, Argentina
  • R.E. Rosenstein
    Hunman Biochemistry, Sch Med–Univ Buenos Aires, Capital Federal, Argentina
  • Footnotes
    Commercial Relationships  M.C. Moreno, None; P.H. Sande, None; N. de Zavalía, None; M.I. Keller Sarmiento, None; H.J. Aldana Marcos, None; R.E. Rosenstein, None.
  • Footnotes
    Support  ANPCyT, University of Buenos Aires
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1283. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.C. Moreno, P.H. Sande, N. de Zavalía, M.I. Keller Sarmiento, H.J. Aldana Marcos, R.E. Rosenstein; Effect of Ocular Hypertension on the Retinal Glutamate/Glutamine Cycle Activity . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1283.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Glutamate–induced excitotoxicity has been proposed to mediate the death of retinal ganglion cells in glaucoma. The metabolic dependence of glutamatergic neurons upon glia via the glutamate/glutamine cycle to provide the precursor for neurotransmitter glutamate is well established. Thus, the aim of the present work was to study the retinal glutamate/glutamine activity in eyes with hypertension induced by intracameral injections of hyaluronic acid (HA). Methods: Weekly injections of HA were performed unilaterally in the rat anterior chamber, whereas the contralateral eye was injected with saline solution. At 3 or 10 weeks of treatment, glutamate and glutamine uptake and release were assessed using [3H]–glutamate or [3H]–glutamine as radioligands, respectively. In addition, glutamine synthetase (GS) activity was assessed by a spectrophotometric assay, whereas glutaminase activity was measured through the conversion of [3H]–glutamine to [3H]–glutamate. Results: At 3 weeks of treatment with HA a significant decrease of glutamate uptake and GS activity was observed (P< 0.01). Glutamine uptake and release, as well as glutaminase activity significantly increased (P< 0.01) in eyes injected with HA for 3 weeks as compared with vehicle–injected eyes, whereas [3H]–glutamate release did not change in hypertensive eyes. Only the changes in GS activity persisted at 10 weeks of treatment with HA. Conclusions: These results indicate a significant alteration of the retinal glutamate/glutamine cycle activity in hypertensive eyes. Since these changes preceded both functional and histological alterations induced by ocular hypertension, these results support the involvement of glutamate in glaucomatous neuropathy.

Keywords: excitatory neurotransmitters • neurotransmitters/neurotransmitter systems • receptors: pharmacology/physiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×